George, Daniel J. http://orcid.org/0000-0002-0836-8542
Ramaswamy, Krishnan http://orcid.org/0000-0003-0890-0268
Huang, Ahong
Russell, David
Mardekian, Jack http://orcid.org/0000-0003-4851-5161
Schultz, Neil M.
Janjan, Nora
Freedland, Stephen J.
Funding for this research was provided by:
Pfizer (Not applicable, Not applicable, Not applicable, Not applicable, Not applicable, Not applicable, Not applicable, Not applicable)
Astellas Pharma US (Not applicable, Not applicable, Not applicable, Not applicable, Not applicable, Not applicable, Not applicable, Not applicable)
Article History
Received: 21 April 2021
Revised: 13 September 2021
Accepted: 23 September 2021
First Online: 3 November 2021
Competing interests
: DJG: Reports grants from Acerta Pharmaceuticals, other from American Association for Cancer Research, grants and personal fees from Astellas, personal fees from Astrazeneca, personal fees from Axess Oncology, grants, personal fees, and non-financial support from Bayer H/C Pharmaceuticals, grants and personal fees from BMS, grants from Calithera, grants from Capio Biosciences, grants from EMD Serona, grants, personal fees and non-financial support from Exelixis, Inc., personal fees from Flatiron, personal fees from Ipsen, grants and personal fees from Janssen Pharmaceuticals, personal fees from Merck, Sharp & Dohme, personal fees from Michael J Hennessey Assoc, personal fees from Millennium Medical Publishing, personal fees from Modra Pharmaceuticals B.V., personal fees from Myovant Sciences, Inc., personal fees from NCI Genitourinary, personal fees from Nektar Therapeutics, grants and personal fees from Novartis, personal fees from Physician Education Resource, grants and personal fees from Pfizer, grants, personal fees, and non-financial support from Sanofi, personal fees from UroGPO, personal fees and non-financial support from UroToday, personal fees from Vizuri Health Sciences, personal fees from Platform Q, outside the submitted work. KR: Is an employee of Pfizer Inc. and owns stocks or stock options. AH: Is a former employee of STATinMED; STATinMED received compensation from the sponsors for the overall conduct of the study. DR: Is an employee of Pfizer Inc. and owns stocks or stock options. JM: Is a former employee of Pfizer Inc. and owns stock or stock options. NMS: Is an employee of Astellas Pharma, Inc., and owns stocks or stock options. NJ: Is an employee of STATinMED. STATinMED received compensation from the sponsors for the overall conduct of the study. SJF: Reports consulting to Pfizer, Astellas, Janssen, Dendreon, Sanofi, Myovant, Merck, and AstraZeneca, Clovis, and Bayer.